Difference between revisions of "Team:Vilnius-Lithuania/Judging"
Line 114: | Line 114: | ||
<div style="margin-left: 30px;">More information about our human practices activity is in our <a class="clink" href="https://2015.igem.org/Team:Vilnius-Lithuania/Practices">Wiki</a>.</div> | <div style="margin-left: 30px;">More information about our human practices activity is in our <a class="clink" href="https://2015.igem.org/Team:Vilnius-Lithuania/Practices">Wiki</a>.</div> | ||
<ul> | <ul> | ||
− | <li>We cloned a biobrick <a class="clink" href="http://parts.igem.org/Part:BBa_K195613">BB_K195613</a> for <a class="clink" href="https://2015.igem.org/Team:Toulouse">Toulouse team</a>.</li> | + | <li>We cloned a biobrick <a class="clink" href="http://parts.igem.org/Part:BBa_K195613">BB_K195613</a> for <a class="clink" href="https://2015.igem.org/Team:Toulouse">Toulouse team</a>.We also collaborated with other teams, by filling their surveys, disscusing. We've met SDU team from Denmark.</li> |
− | <li>We charachterized BBa_R1051 biobrick by | + | <li>We charachterized BBa_R1051 biobrick by investigating its interaction with the product of BBa_K077039 biobrick. BBa_R1051 is a GFP expressing device that can be repressed by cI protein. We obtained data, which indicates that BBa_R1051 is indeed repressible in vivo conditions by cI and we also hypothesize that even cI production from BBa_K077039 biobrick is highly unpredictable in our conditions.</li> |
</ul> | </ul> | ||
Revision as of 21:59, 18 September 2015